1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Prostate cancer

MRI fusion biopsy systems for diagnosing prostate cancer

Diagnostics guidance [DG53] Published: 24 May 2023

Register as a stakeholder
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Research recommendation(s) from an individual piece of guidance

Guidance:
MRI fusion biopsy systems for diagnosing prostate cancer
Date issued:
24 May 2023

Research recommendations coming out of this guidance

  • Further research is recommended to determine the impact of MRI fusion biopsy systems compared with cognitive fusion biopsy on the detection of different grades of prostate cancer.

  • Further data collection or research is recommended on the impact of implementing MRI fusion biopsy systems on the rate at which biopsies can be done, capacity resources and waiting times for this procedure.